SB203580—A Potent p38 MAPK Inhibitor Reduces the Profibrotic Bronchial Fibroblasts Transition Associated with Asthma
Milena Paw(Jagiellonian University), Marta Michalik(Jagiellonian University)
Cited by 34
Related Papers
PPARδ Agonist GW501516 Suppresses the TGF-β-Induced Profibrotic Response of Human Bronchial Fibroblasts from Asthmatic Patients
|International Journal of Molecular Sciences|2023|10